SCHEDULE: Neogenomics Stake: First Light Asset Management Discloses Holdings

First Light Asset Management, LLC and Mathew P. Arens have jointly filed a Schedule 13G, reporting beneficial ownership of over 10% of Neogenomics, Inc. common stock as of April 30, 2026.

Summary

• First Light Asset Management, LLC and Mathew P. Arens have jointly filed an amended Schedule 13G, reporting their beneficial ownership of Neogenomics, Inc. common stock.
• As of April 30, 2026, First Light Asset Management, LLC beneficially owns 13,631,016 shares, representing 10.47% of the class.
• Mathew P. Arens beneficially owns 14,093,416 shares, representing 10.82% of the class, which includes shares held directly and indirectly through the Manager.
• The filing indicates that First Light Asset Management, LLC acts as an investment adviser to accounts and private funds holding these shares.
• Mathew P. Arens controls First Light Asset Management, LLC as its managing member and majority owner.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily discloses ownership information without providing performance metrics or strategic commentary that would indicate a positive or negative outlook.

Positives

• Significant beneficial ownership stake of over 10% in Neogenomics, Inc. by First Light Asset Management, LLC and Mathew P. Arens.
• Clear disclosure of holdings and roles, indicating transparency in ownership.

Risks

• Potential for increased scrutiny from regulators due to the significant ownership stake.
• The filing does not provide details on the investment strategy or reasons for acquiring the stake, which could be a point of interest for other investors.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance or strategy.

Management Comments

• The Manager may be deemed to be the beneficial owner of these shares because it acts as an investment adviser to certain private funds.
• Mr. Arens may also be deemed to be the beneficial owner of these shares because he controls the Manager in his position as managing member and majority owner of the Manager.
• The filing of this Schedule 13G shall not be construed as an admission that the reporting persons or any of their affiliates are the beneficial owner of any securities covered by this Schedule 13G for any other purposes other than Section 13(d) of the Securities Exchange Act of 1934.

Industry Context

StockSavvy.ai notes that significant ownership filings like this Schedule 13G often precede or coincide with activist investor campaigns or strategic shifts within a company. The substantial stake held by First Light Asset Management suggests a strong conviction in Neogenomics' potential or a desire to influence its direction.

Stakeholder Impact

• Shareholders: The significant stake may lead to increased focus on corporate governance and strategic decisions, potentially impacting share price.
• Management: May face increased engagement or pressure from First Light Asset Management and Mathew P. Arens regarding company strategy and performance.

Next Steps

• Monitor Neogenomics, Inc. for any strategic announcements or changes that may be influenced by the significant stake held by First Light Asset Management and Mathew P. Arens.
• Observe potential future filings from these reporting persons that might provide more insight into their intentions.

Key Dates

Keywords

Neogenomics, Schedule 13G, First Light Asset Management, Mathew P. Arens, Beneficial Ownership, SEC Filing, Common Stock, Investment Adviser